Jefferies Financial Group Issues Positive Forecast for Tenet Healthcare (NYSE:THC) Stock Price

Posted by Defense World Staff on Feb 13th, 2026

Tenet Healthcare (NYSE:THC – Free Report) had its price target raised by Jefferies Financial Group from $250.00 to $265.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock.

A number of other equities analysts have also recently issued reports on the stock. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Thursday. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. Truist Financial reaffirmed a “buy” rating and set a $240.00 target price (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. Finally, Wells Fargo & Company decreased their price target on Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus target price of $241.00.

Get Our Latest Stock Report on THC

Tenet Healthcare Stock Up 2.7%

Shares of THC stock opened at $232.55 on Thursday. The company has a quick ratio of 1.64, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The company has a market capitalization of $20.44 billion, a price-to-earnings ratio of 15.01, a P/E/G ratio of 0.95 and a beta of 1.44. The firm has a fifty day moving average of $198.41 and a 200-day moving average of $194.17. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $235.77.

Tenet Healthcare (NYSE:THC – Get Free Report) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts predict that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.81% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Advisors Asset Management Inc. grew its stake in shares of Tenet Healthcare by 161.9% during the 4th quarter. Advisors Asset Management Inc. now owns 6,706 shares of the company’s stock valued at $1,333,000 after purchasing an additional 4,145 shares during the period. Federation des caisses Desjardins du Quebec raised its stake in Tenet Healthcare by 4.1% during the 4th quarter. Federation des caisses Desjardins du Quebec now owns 19,583 shares of the company’s stock worth $3,892,000 after acquiring an additional 765 shares during the period. Leith Wheeler Investment Counsel Ltd. lifted its position in shares of Tenet Healthcare by 2.3% in the fourth quarter. Leith Wheeler Investment Counsel Ltd. now owns 52,239 shares of the company’s stock valued at $10,381,000 after acquiring an additional 1,170 shares in the last quarter. Brooklyn Investment Group boosted its stake in shares of Tenet Healthcare by 19.3% in the fourth quarter. Brooklyn Investment Group now owns 5,100 shares of the company’s stock worth $1,026,000 after acquiring an additional 824 shares during the period. Finally, California Public Employees Retirement System raised its position in shares of Tenet Healthcare by 39.2% during the 4th quarter. California Public Employees Retirement System now owns 231,467 shares of the company’s stock valued at $45,997,000 after buying an additional 65,157 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

Positive Sentiment: Q4 beat and strong results: Tenet reported $4.70 EPS vs. $4.08 est. and $5.53B revenue (up ~8.9% YoY); management highlighted revenue and EBITDA growth that underpins the market rally. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
Positive Sentiment: Raised 2026 outlook: Tenet issued EPS guidance of $16.19–$18.47 and an adjusted EBITDA target of $4.485B–$4.785B, signaling confidence in cash flow and M&A optionality. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target amid structural cost initiatives and M&A focus
Positive Sentiment: Analyst upgrade/price-target lift: Jefferies raised its price target to $265 and keeps a Buy rating, providing additional analyst support for further upside. Jefferies Raises Price Target to $265 (Benzinga)
Positive Sentiment: Market reaction: Shares hit a new one‑year/all‑time high on the beat and outlook, indicating strong investor appetite after the results. Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings
Neutral Sentiment: Full earnings materials and call transcripts are available for deeper review (slides and transcript show drivers behind the guide and cost initiatives). Tenet Healthcare Corporation 2025 Q4 – Results – Earnings Call Presentation
Negative Sentiment: Policy headwind: Tenet expects about a $250M hit this year from the loss of ACA subsidies, a near‑term earnings and cash‑flow headwind investors must account for. Tenet expects $250M hit from loss of ACA subsidies this year
Negative Sentiment: Margin risk for 2026: Some analysts note the guidance midpoint implies potential pressure on 2026 EBITDA margins even as revenue guidance was lifted — monitor margin execution and cost initiatives closely. Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.